Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors [Phase 2]
Phase 2 trial evaluating gefitinib in EGFR amplification–refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation [Phase 2]
Phase 2 study of selpercatinib (Retevmo) in adults with advanced RET-altered solid tumors, including RET fusion–positive cancers and medulla…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) [Phase 1]
Phase 1 trial update of vorinostat in patients with solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of F16IL2 with paclitaxel in solid tumors, including breast cancer, completed.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells [Phase 1, Phase 2]
Clinical trial update investigating metoprolol for treating cytokine release syndrome in patients receiving CAR-T therapy, across Phase 1 an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel [Phase 1]
Phase 1 study evaluating bioequivalence of Oraxol in cancer patients treated with intravenous paclitaxel has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: A Phase I Trial of AZD3965 in Patients With Advanced Cancer [Phase 1]
Phase I trial of AZD3965 in adults with advanced cancer, including diffuse large B-cell lymphoma and Burkitt lymphoma, completed with result…
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors [Phase 1, Phase 2]
A study evaluating the activity, safety, and tolerability of ZX-101A in advanced solid tumors across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors [Phase 2]
Phase 2 exploratory basket trial of pyrotinib maleate in HER2-mutated or amplified metastatic solid tumors; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating HMPL-453 (FGFR inhibitor) combined with chemotherapy or anti-PD-1 antibody in advanced solid tumors; current stat…
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy [Phase 1, Phase 2]
Clinical trial updates on GC1118 combined with chemotherapy are completed in Phase 1/2 for metastatic colorectal cancer and solid tumors.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208) [Phase 1, Phase 2]
Trial update for Epacadostat and Nivolumab in combination with other therapies in advanced/metastatic solid tumors; study terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of CB-839 (telaglenastat) in combination with talazoparib in solid tumors was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) [Phase 2]
Phase 2 trial update for tilsolotolimod in combination with nivolumab and ipilimumab for solid tumors; status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for SHR-1701 in combination with famitinib in advanced solid tumors across phase 1 and phase 2.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor [Phase 2]
Phase 2 trial evaluating an anti-PD-1 antibody in a multimodal combination as first-line treatment for advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors [Phase 2]
Phase 2 study of the PD-L1 Probody therapeutic CX-072 in combination with other anticancer therapy in adults with solid tumors, including un…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours [Phase 1]
Phase 1 dose-escalation and expansion study of IPN60090 in patients with advanced solid tumors; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 study of YL-15293 in advanced solid tumors with KRAS G12C mutation is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) [Phase 2]
Phase 2 clinical trial evaluating ADC with hypofractionated radiotherapy followed by sequential PD-1/PD-L1 blockade with GM-CSF and IL-2 for…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients [Phase 2]
Phase 2 clinical trial investigating local radiotherapy in combination with immunotherapy for advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating galunisertib in combination with nivolumab for advanced solid tumors, including recurrent or refractory non-small…
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3415244 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of LY3415244 in advanced solid tumors was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.